AVIZAKIMAB
UNII 4H3BBE5WVK

Substance Identification & Data

This profile provides standardized clinical and technical data for Avizakimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4H3BBE5WVK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2229685-51-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4H3BBE5WVK

CAS Registry Number

2229685-51-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AVIZAKIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C171825

National Cancer Institute reference terminology for clinical and research data.

INN ID

11148

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Avizakimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AVIZAKIMAB

Common Names & Synonyms

AVIZAKIMAB [INN]

AVIZAKIMAB [WHO-DD]

IMMUNOGLOBULIN G1 (251-TYROSINE,253-THREONINE,255-GLUTAMIC ACID), ANTI-(HUMAN INTERLEUKIN 21) (HUMAN-MUS MUSCULUS MONOCLONAL BOS161721 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BOS161721 .KAPPA.-CHAIN, DIMER

MEDI 7169 [WHO-DD]